Carolyn Weeks-Levy;Beth-Ann Coller;Steven A. Ogata;Vidya Pai
发明人:
Beth-Ann Coller,Vidya Pai,Carolyn Weeks-Levy,Steven A. Ogata
申请号：
US13322784
公开号：
US20120141520A1
申请日:
2010.06.01
申请国别(地区):
US
年份:
2012
代理人:
摘要：
A West Nile virus vaccine for human use is described that preferably contains a recombinantly produced form of truncated West Nile virus envelope glycoprotein and aluminum adjuvant. The vaccine is acceptable for use in the general population, including immunosuppressed, immunocompromised, and immunosenescent individuals. The vaccine is safe and effective for use in all healthy and at-risk populations. A pharmaceutically acceptable vehicle may also be included in the vaccine.
